paraquat has been researched along with carvacrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, F; Boskabady, MH; Kazerani, HR; Memarzia, A; Rad, HK | 1 |
| Amin, F; Boskabady, MH; Kazemi Rad, H; Memarzia, A; Shakeri, F | 1 |
2 other study(ies) available for paraquat and carvacrol
| Article | Year |
|---|---|
Carvacrol and PPARĪ³ agonist, pioglitazone, affects inhaled paraquat-induced lung injury in rats.
Topics: Animals; Case-Control Studies; Cymenes; Dexamethasone; Disease Models, Animal; Drug Synergism; Gene Expression Regulation; Interleukin-6; Lung Injury; Male; Oxidative Stress; Paraquat; Pioglitazone; Rats; Rats, Wistar; Transforming Growth Factor beta; Treatment Outcome | 2021 |
Systemic inflammation and oxidative stress induced by inhaled paraquat in rat improved by carvacrol, possible role of PPARĪ³ receptors.
Topics: Administration, Inhalation; Animals; Cymenes; Disease Models, Animal; Herbicides; Inflammation; Lung; Male; Oxidative Stress; Paraquat; PPAR gamma; Rats; Rats, Wistar | 2021 |